InMode rises after issuing guidance above consensus

Ralf Hahn InMode ( NASDAQ: INMD ) rose ~3% Tuesday pre market after the medical technologies company issued guidance above consensus. Q4 revenue is expected to be in the range of $126.0M to $126.5M, vs. consensus of $123.42M. 2023 revenue is estimated to be between $491.3M and $491.8M, vs. consensus of $488.71M.

Q4 non GAAP EPS should be in the range of $0.68 to $0.69, vs. consensus of $0.61. 2023 EPS should come between $2.54 to $2.55, vs. consensus of $2.47. 2023 non GAAP gross margin should be in the range of 83% to 85%. 2024 revenue is estimated to be in the range of $495M to $505M, below consensus of $519.84M.

InMode is set to hold a conference call to discuss its Q4 financial results on Feb. 13. Source: Press Release More on InMode InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In Here's Why InMode Is Inherently Undervalued Bullish Support Observed InMode: A Deep Analysis Into Its Mixed Picture Inmode stock slides after macro conditions weigh on annual outlook UBS cuts InMode to neutral, says macro factors clouding visibility.